Skip to content

ORBIMED ADVISORS LLC: ETRA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ETRA, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 6,885,170 ETRA shares at 2026-09-30 per its 13F-HR filed 2026-11-16, and reported 7,449,857 shares in a Form 4 filed 2026-11-10.

Estimated current stake: 7,449,857 shares

Estimated from Form 4 of 2026-11-10. As of 2026-11-10, Form 4 0000947871-26-001010.

Shares are the reporting owners' post-transaction amount in the lines that filing reports.

Percent of portfolio stays on the 13F for 2026-09-30.

  1. transaction date2026-11-10
    F4 7,449,857 shares
    Transaction change +2,000 shares

    (code P, bought) at $8.45.

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,255,278 shares
    • Indirect See footnotes : 2,194,579 shares
  2. transaction date2026-11-10
    F4 7,447,857 shares
    Transaction change +20,700 shares

    (code P, bought) at $8.45.

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,255,278 shares
    • Indirect See footnotes : 2,192,579 shares
  3. transaction date2026-11-09
    F4 7,427,157 shares
    Transaction change +16,000 shares

    (code P, bought) at $8.24.

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,234,578 shares
    • Indirect See footnotes : 2,192,579 shares
  4. transaction date2026-11-09
    F4 7,411,157 shares
    Transaction change +4,000 shares

    (code P, bought) at $8.24.

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,234,578 shares
    • Indirect See footnotes : 2,176,579 shares
  5. transaction date2026-11-06
    F4 7,407,157 shares
    Transaction change +39,600 shares

    (code P, bought) at $7.85.

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,230,578 shares
    • Indirect See footnotes : 2,176,579 shares
  6. transaction date2026-11-06
    F4 7,367,557 shares
    Transaction change +9,816 shares

    (code P, bought) at $7.85. Different basis (another filing's ownership lines).

    Form 4 0000947871-26-001010 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,230,578 shares
    • Indirect See footnotes : 2,136,979 shares
  7. transaction date2026-11-05
    F4 7,357,741 shares
    Transaction change +125,200 shares

    (code P, bought) at $7.31.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,220,762 shares
    • Indirect See footnotes : 2,136,979 shares
  8. transaction date2026-11-05
    F4 7,232,541 shares
    Transaction change +30,891 shares

    (code P, bought) at $7.31.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,220,762 shares
    • Indirect See footnotes : 2,011,779 shares
  9. transaction date2026-11-04
    F4 7,201,650 shares
    Transaction change +20,000 shares

    (code P, bought) at $7.07.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,189,871 shares
    • Indirect See footnotes : 2,011,779 shares
  10. transaction date2026-11-04
    F4 7,181,650 shares
    Transaction change +5,000 shares

    (code P, bought) at $7.07.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,189,871 shares
    • Indirect See footnotes : 1,991,779 shares
  11. transaction date2026-11-04
    F4 7,176,650 shares
    Transaction change +37,100 shares

    (code P, bought) at $7.78.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,184,871 shares
    • Indirect See footnotes : 1,991,779 shares
  12. transaction date2026-11-04
    F4 7,139,550 shares
    Transaction change +9,267 shares

    (code P, bought) at $7.78.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,184,871 shares
    • Indirect See footnotes : 1,954,679 shares
  13. transaction date2026-11-03
    F4 7,130,283 shares
    Transaction change +98,600 shares

    (code P, bought) at $7.88.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,175,604 shares
    • Indirect See footnotes : 1,954,679 shares
  14. transaction date2026-11-03
    F4 7,031,683 shares
    Transaction change +24,400 shares

    (code P, bought) at $7.88.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,175,604 shares
    • Indirect See footnotes : 1,856,079 shares
  15. transaction date2026-11-03
    F4 7,007,283 shares
    Transaction change +97,800 shares

    (code P, bought) at $7.84.

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,151,204 shares
    • Indirect See footnotes : 1,856,079 shares
  16. transaction date2026-11-03
    F4 6,909,483 shares
    Transaction change +24,313 shares

    (code P, bought) at $7.84. Different basis (the reporting owners' lines in a Form 3, 4 or 5).

    Form 4 0000947871-26-000985 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    • Indirect See footnotes : 5,151,204 shares
    • Indirect See footnotes : 1,758,279 shares
  17. period ended2026-09-30
    13F 6,885,170 shares
    Share basis changed not comparable

    Different basis (13F positions of the group's filers). 1.42% of the 13F portfolio, value $77,458,163.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  18. event date2026-09-21
    13D 6,885,170 shares
    Change vs previous stake not available

    11% of the class.

    13D 0000947871-26-000898 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.